Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
GenprexGNPX | Open-market sale | 04/14 | 04/15 | 18 sh2 trades | $1.23avg. | $22.14 | No record | |
Catherine M. VaczyEVP GC Chief Strategy Officer | GenprexGNPX | Open-market buy | 23/04/21 | 23/04/24 | 20,000 sh | $1.07 | $21,400 | +8.2% |
John Rodney VarnerChairman, President and CEO | GenprexGNPX | Open-market buy | 23/04/21 | 23/04/24 | 19,000 sh | $1.06 | $20,140 | +1055.6% |